Iodine I-124 Evuzamitide for spinal stenosis

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 2 Apr 2025: Trial registered, NCT06907849
  2. 22 May 2025: Trial started, NCT06907849

The trials

NCT06907849: 124I-Evuzamitide PET/CT Imaging In Patients With Lumbar Spinal Stenosis and Carpal Tunnel Syndrome

State
Under way
Phase
Phase 2
People
40 planned
Started
22 May 2025
Primary completion
Mar 2027
Arms
Biodistribution
Results
None posted
  1. 2 Apr 2025: Trial registered
  2. 22 May 2025: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Also known as 124I-evuzamitide.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.